Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Novedo acquires the Danish industrial company Stantraek A/S with annual sales of ca 220 MSEK

Novedo Holding AB (publ), a niche industrial group within Industry, Infrastructure and Installation & Services, has today acquired the Danish industrial company Stantraek A/S, which specializes in customized components and sheet metal parts for industrial applications. Stantraek's sales for 2022 amounted to approximately SEK 220 million. Closing is expected to take place in Q1 2023. Following the acquisition, Novedo's pro formed net sales amount to approximately SEK 2.7 billion and pro forma EBITA to approximately SEK 300 million.Novedo continues to grow in the Industry business segment and

BioStock: Further steps in Aptahem's phase I study

At the end of December 2022, biotech company Aptahem announced the completion of cohort 1 in healthy volunteers for the phase I study with the sepsis candidate Apta-1. Now, the second dose cohort is also ready and approved by the Dutch Ethics Committee and dose cohort three has started. BioStock talked to CEO Mikael Lindstam to learn more.Read the full interview with Aptahem´s CEO Mikael Lindstam at biostock.se: https://www.biostock.se/en/2023/02/further-steps-in-aptahems-phase-i-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Penneo realizes 28% ARR growth rate in 2022

Company Announcement No. 03-2023 Copenhagen, 28 February 2023 Penneo releases financial report for the period 1 January 2022 - 31 December 20222022 Performance highlights · ARR amounted to 71.0M DKK at the end of 2022 compared to 55.5M DKK at the end of 2021 which corresponds to a YoY growth rate of 28% · YoY ARR newbiz amounted to 15%  · YoY ARR uplift amounted to 16% · YoY ARR churn rate amounted to 4% · YoY net ARR retention rate amounted to 113% · ARR from foreign markets amounted to 19.6M DKK at the end of 2022 compared to 14.4M DKK at the end of 2021 (36% YoY

Innkalling til ordinær generalforsamling 2023

Ordinær generalforsamling i Gjensidige Forsikring ASA avholdes torsdag 23. mars 2023 kl. 17.00. Det vil være mulig å delta enten digitalt eller fysisk, sistnevnte på Gjensidige Forsikring ASAs hovedkontor, Schweigaards gate 21, 0191 Oslo. Innkalling med dagsorden til generalforsamlingen samt utvalgte vedlegg følger vedlagt. Innkallingen sendes til aksjeeierne 28. februar 2023. Innkalling med samtlige vedlegg gjøres tilgjengelig på Gjensidiges nettsider www.gjensidige.com/no/foretaksstyring. Denne meldingen er informasjonspliktig etter verdipapirhandelloven §5-12 Kontaktperson,

Notice of Annual General Meeting 2023

The Annual General Meeting of Gjensidige Forsikring ASA will be held Thursday 23 March 2023 at 17:00 (CET). There is possibility of either digital or physical attendance, the latter at Gjensidige Forsikring ASA’s head office, Schweigaards gate 21, 0191 Oslo. The notice including agenda for the General Meeting and selected appendices are attached to this disclosure. The notice will be sent to shareholders on 28 February 2023. The notice with complete appendices will be made available on Gjensidige's web pages, https://www.gjensidige.no/group/investor-relations/corporate-governance.

Interim Report 4, October – December 2022

Klimator AB (publ) Financial Statement 2022 Interim Report 4, October – December 2022     Fourth quarter October 1 – December 31, 2022 Group · Operating income amounted to SEK 8,121K (SEK 7,431K) · Operating profit amounted to SEK -6,214K (SEK -5,545K) · Net profit after income taxes amounted to SEK -6,530K (SEK -5,581K) · Net profit per share after income taxes amounted to SEK -0.42 (SEK -0.36)       (Amounts within parentheses refer to the corresponding figures for the same period               the prior year) Full year January 1 – December 31, 2022

AegirBio UK facility ISO 13485 compliant

We are pleased to announce that our product development site in the UK has been successfully, independently assessed and found to be compliant with ISO 13485:2016.The ISO 13485 certification is an endorsement of the Quality Management System (QMS) that underpins the Company's position as a trusted manufacturer of medical devices. The accreditation is recognised on an international scale and is a critical part of gaining regulatory approval for our products. Moreover this development is important in enabling the Company to operate with greater capacity and improved efficiency and is a

RLS Global AB (publ) Year-end Report, Q4, 2022

OCTOBER 1st – DECEMBER 31st (previous year in brackets) · Net sales amounted to TSEK 291 (TSEK 219) · Earnings before interest and taxes (EBIT) amounted to MSEK -7,9 (MSEK -7,8) · Earnings per share after dilution at SEK -0,10 (SEK 0,09) · Cash flow from operating activities amounted to TSEK -5 779 (TSEK -4 887) · Liquid assets at the end of the period MSEK 20,5 ( MSEK 11,5) · Equity ratio was 83 % (75 %)  JANUARY 1st – DECEMBER 31st (previous year in brackets) · Net sales amounted to TSEK 1 198 (TSEK 653) · Earnings before interest and taxes (EBIT) amounted

RightBridge Ventures Group AB interim Q4 and full 2022 year financial report

SOLID FULL-YEAR GROWTH, EARNINGS WEIGHTED DOWN BY ONE – OFF, NON–CASH ITEMS and NEWLY ONBOARDED INVESTMENT.   GROUP RESULTS FULL YEAR 2022 Revenues. The Group’s net sales amounted to to 8,445KSEK (-).   Earnings. The Group’s net results for the full year were – 15 477KSEK (-3 042KSEK). Including non – cash affecting items. The Group’s adjusted net results, excluding the non–cash item of 1) the cost of the reverse takeover at -11 379KSEK and 2) goodwill amortization at -1 536KSEK,  amounted to -2 562KSEK (-3 042KSEK).   Earnings per share* amounted to SEK -0.36

Eurocine Vaccines discloses half-year report for July – December 2022

Eurocine Vaccines AB (publ) (“Eurocine Vaccines” or the “Company”) hereby discloses the half-year report for July to December 2022. Below is a summary of the report. The full report is available on Eurocine Vaccines’ website and as an attachment.   2022-10-01– 2022-12-31 (second quarter) · Results after tax for the quarter amounted to -6.2 MSEK (-5.3 MSEK) · Revenues for the quarter amounted to 1 KSEK (0 KSEK) · Earnings per share for the quarter amounted to -0.222 SEK (-0.373 SEK) 2022-07-01 – 2022-12-31 (first six months) · Results

“3D imaging is even better than a microscope”

When Dr Sirpa Pöyry makes a diagnosis, she is always confident in her findings. That’s because, more often than not, she has based her decision on a detailed 3D image of the area of interest. Today, the 3D images obtained with the clinic’s Planmeca Viso® G7 CBCT imaging unit are an indispensable part of her daily work and a tool she “would never go without.” It’s a common enough story. The patient complains of a tooth ache. Their treatment history shows the tooth has undergone root canal therapy some years ago. The panoramic image reveals an infection at the root. Will retreatment

Accedian and VMware Tighten Interoperability to Better Assure CSP Services Delivered Across Open RAN, MEC, and 5G Core

BARCELONA, Mobile World Congress 2023 – February 28, 2023 – Accedian , a leader in performance analytics, cybersecurity threat detection, and end-user experience solutions, today announced that its cloud-native Skylight service assurance solution is now interoperable with the VMware Telco Cloud  Platform . The validated integration will allow communications service providers (CSPs) to automatically onboard, catalog, and deploy containerized testing

Notice to the annual general meeting in Bonava AB (publ)

The shareholders of Bonava AB (publ), 556928-0380, ("Bonava"), are hereby invited to attend the annual general meeting, to be held on Monday, 3 April 2023 at 15.00, at Finlandshuset, Snickarbacken 4, Stockholm, Sweden. Registration for the annual general meeting will open at 14.30.The board of directors has decided that the shareholders may also exercise their voting right by postal voting, pursuant to article 13 in Bonava’s Articles of Association. Participation Shareholders who wish to attend the annual general meeting shall: · be listed in the shareholders' register maintained

Aker Solutions Wins Umbilicals Contract for the Agogo Field Development in Angola

February 28, 2023 – Aker Solutions has been awarded a sizeable[1] contract by Eni Angola S.p.A. – Sucursal de Angola, a subsidiary of Azule Energy Holdings Limited ("Azule Energy ”), to provide the dynamic and static subsea umbilicals for the Agogo field development located offshore Angola in the West Hub Area of Block 15/06.The contract includes the engineering, manufacturing and delivery of a complete umbilical system totaling about 36 kilometers of both dynamic and static subsea production control umbilicals including spares, as well as ancillary equipment and services. The umbilicals

Decreased number of shares and voting rights in Catena Media plc

Catena Media plc announces that the number of shares and voting rights in the company has decreased by 4,295,510 following the cancellation of ordinary shares which took place on 1 February 2023. As of 28 February 2023, the last trading day of the month, the number of shares and voting rights in Catena Media has decreased from 76,330,859 to 72,035,349 and share capital has decreased by EUR 6,443.27 to EUR 108,053.02.  Contact details for further information: Investor RelationsEmail: ir@catenamedia.com Peter Messner, Group CFOEmail: peter.messner@catenamedia.com This

Year-end report 2022 with interim report Q4

October - December 2022 Net sales increased by 21.3% Y-O-Y. Consolidated net sales ended at 69,611 (SEK 000s). EBITDA totaled -34,715 (SEK 000s). Operating profit, EBIT, was -65,535 (SEK 000s). Profit after tax was -67,491 (SEK 000s). Earnings per share was SEK -0.993. January - December 2022 Net sales increased by 21,9% Y-O-Y. Consolidated net sales ended at 257,162 (SEK 000s). EBITDA totaled -101,945 (SEK 000s). Operating profit, EBIT, was -190,808 (SEK 000s). Profit after tax was -218,299 (SEK 000s). Earnings per share was SEK -3.212.CEO's comments 2022 has been a demanding

Neste and ILLIG to showcase more sustainable solutions for thermoformed plastic packaging through demonstration cases

Neste Corporation, Press Release, 28 February 2023 at 9.00 a.m. (EET) Photo: Jürgen Lochner, CSO/CTO at ILLIG and Mercedes Alonso, Executive Vice President Renewable Polymers and Chemicals at Neste. Source: Neste   · Neste and ILLIG to build demonstration cases to showcase the benefits and feasibility of more sustainable solutions for thermoformed plastic packaging · The cooperation targets an acceleration in the shift away from fossil resources and to renewable and recycled materials Neste and ILLIG have entered into a strategic partnership to advance the use of more

Inhalation Sciences AB (publ) releases Year-End Report 2022

(Stockholm, Sweden, 28 February 2023) Inhalation Sciences AB announces that its Year-End Report for 2022 is now available on the company’s website. To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/Summary of Year-End Report · Net revenue for the full year 2022 increased by 29% compared to 2021 · Sales for the full year 2022 increased by 74% compared to 2021 · Sales for Q4 2022 increased by 23% compared to the same period in 2021 · The company had an order backlog of SEK 9.1M in December 2022 compared to SEK 5M in the same

Notice of the Annual General Meeting of Cloetta AB (publ)

Shareholders of Cloetta AB (publ), reg. no. 556308-8144, are hereby invited to attend the Annual General Meeting, to be held on Tuesday, 4 April 2023 at 3.00 p.m. CET at Courtyard by Marriott, Rålambshovsleden 50 in Stockholm, Sweden. Registration will commence at 2.00 p.m. CET.The Board of Directors has resolved that shareholders may also exercise their voting right at the Annual General Meeting by postal voting pursuant to the provisions in the Articles of Association of Cloetta. Right to attend the meeting and noticeShareholders who wish to participate in the Annual General Meeting

Q4 and full year report January – December 2022

Significant increase of operating profit in 2022Highlights fourth quarter 2022 · Gross collections amounted to EUR 16.4m (17.6)* · Net collections amounted to EUR 14.2m (15.0)* · Cash EBITDA amounted to EUR 10.2m (12.7)* · Net loss for the period of EUR 0.2m (profit 1.0)* · Gross ERC at the end of December 2022 was EUR 283m (297 at December 2021) · Cash at the end of December 2022 was EUR 52.3m (62.8 at December 2021) Highlights full year 2022 · Gross collections amounted to EUR 70.8m (56.9)* · Net collections amounted to EUR 61.2m (47.6)* · Cash EBITDA

Q4 and full year report January – December 2022

Significant increase of operating profit in 2022Highlights fourth quarter 2022 · Gross collections amounted to EUR 16.6m (18.7)* · Net collections amounted to EUR 14.4m (15.3)* · Cash EBITDA amounted to EUR 10.6m (11.8)* · Net profit for the period of EUR 0.1m (0.1)* · Gross ERC at the end of 2022 was EUR 284m (299 at December 2021) · Cash at the end of 2022 was EUR 52.6m (65.5 at December 2021) Highlights full year 2022 · Gross collections amounted to EUR 71.9m (61.7)* · Net collections amounted to EUR 62.3m (50.1)* · Cash EBITDA amounted to EUR 50.6m (38.

Esmaeilzadeh Holding publishes year-end report for 2022

“We are leaving an eventful year behind us that has been formative for EHAB and our investment portfolio. We have taken methodical strides in establishing ourselves as an entrepreneurial investment company with profitability and long-term sustainability as its basic idea. This is substantiated by the journeys our portfolio companies have been through, which have resulted in new levels of maturity, size, and stability. We head into the new year with strong confidence from the capital market, a well-proven strategy, and the necessary organisation for implementing our plans for 2023.” - Saeid

Year-end report and interim report for the period 1 October 2022 – 31 December 2022

published at 08:00 on 28 February 2023 Wicket Gaming AB (”Wicket Gaming” or the ”Company”) publishes interim report for the period 1 October 2022 – 31 December 2023.Summary of the period The Group arose during the fourth quarter, and consequently no comparison is made with the corresponding period in the previous year. The information for the period 01/01/2022 – 31/12/2022 includes the whole year for the Parent Company and the fourth quarter for the Group. Fourth quarter 01/10/2022 – 31/12/2022 (Group) · Net sales: SEK 6,883 thousand. · Earnings before interest, taxes,

Year-end report 2022

MindArk PE AB (publ) ("MindArk", the "Company") hereby announces that the Company's year-end report for 2022 and interim report for the fourth quarter of 2022 have now been published.Comment from CEO Henrik Nel Jerkrot: “It is with great pleasure that with our first financial report as a listed company, we have had a record quarter in terms of net revenue. During the quarter, we have been working extensively on  the graphics engine transition to Unreal Engine 5. However, we have been careful not to let this affect the user experience or content creation in the current Entropia Universe.

There are no items matching the current filter
There are no more items matching the current filter
Back to top